-
Cost-Effectiveness Analysis of Protocol Biopsy and Non-Invasive Biomarkers for Monitoring Transplant Rejection Within One-Year Post-Kidney Transplants
Mar 10, 2025, 14:00 PM -
Estimating Healthcare Resource Utilization and Direct Costs of Chronic Myeloid Leukemia in the Brazilian Public Health System
Mar 10, 2025, 14:00 PM -
The Relationship Between Weight and Disease Severity in Dogs with Chronic Kidney Disease: Results from a Real-World Study
Mar 10, 2025, 14:00 PM -
Why It Is Still Important to Ensure the Price is Right: Updates to Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy
Mar 10, 2025, 14:00 PM -
Assessing the Budget Impact and Time Savings of Introducing Nivolumab and Hyaluronidase SC to Patients Receiving Nivolumab IV Across Multiple Indications on a US Healthcare Plan
Mar 10, 2025, 14:00 PM -
Estimated Impact of Pre-Exposure Prophylaxis for COVID-19 on Quality of Life and Physical Distancing Among Immunocompromised Individuals and Caregivers
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization by Severity of Disease Among Adult Patients With Asthma in the United States
Mar 10, 2025, 14:00 PM -
Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Type 2 Diabetes Mellitus
Mar 10, 2025, 14:00 PM -
China's National Reimbursement Drug List (NRDL) Negotiation: Value Considerations and Key Factors Influencing Payment Standards
Mar 10, 2025, 14:00 PM -
Assessing the Completeness of Oncology Treatment Data from Administrative Claims: A Benchmarking Study Against Abstracted EHRs Using Patient-Level Linkages
Mar 10, 2025, 14:00 PM -
Obesity Impact on Incidence of Chronic Comorbid Conditions
Mar 10, 2025, 14:00 PM -
Evaluating PICOs Requested by Member States During Scoping for EU HTA Versus Those Covered in Actual HTAs
Mar 10, 2025, 14:00 PM -
Contemporary Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of German Claims Data
Mar 10, 2025, 14:00 PM -
Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in HER2-Positive Early Breast Cancer in China: A Post-Hoc Analysis of the FeDeriCa Trial
Mar 10, 2025, 14:00 PM -
A Cost Per Responder Analysis of Ritlecitinib and Baricitinib: Assessing the Impact of Clinical Efficacy and Dosing Variability on Overall Treatment Costs of Severe Alopecia Areata (AA)
Mar 10, 2025, 14:00 PM -
Exploring Contemporary Variability in PDMP Budgets and Data Sharing Across the United States
Mar 10, 2025, 14:00 PM -
The Use of QALYs in Decision-Making in Europe, Canada, and the US: A Qualitative Review of Methodological Guidance
Mar 10, 2025, 14:00 PM -
Advancing Health Equity in Economic Evaluations, With The Distributional Generalized Risk-Adjusted Cost-Effectiveness (DGRACE) Model
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China
Mar 10, 2025, 14:00 PM
